2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow PF-05230907: new trials by email Literature Review of PF-05230907 trials Research Report on PF-05230907
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage PF-05230907 - Intracerebral Hemorrhage | Phase 1 | Terminated | Pfizer | 21 | 2016-11-01 | 2019-04-17 |
| Single Dose Study of PF-05230907 in Healthy Japanese Subjects PF-05230907, Placebo - Healthy | Phase 1 | Completed | Pfizer | 17 | 2015-09-01 | 2016-04-29 |
| A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers PF-05230907, Placebo for PF-05230907 - Healthy | Phase 1 | Completed | Pfizer | 49 | 2013-09-01 | 2016-04-22 |
Cerebral Hemorrhage (1) · Hematoma (1) · Hemorrhage (1)
Pfizer (3)
United States (2) · Belgium (1) · Canada (1) · Spain (1) · United Kingdom (1)
2015 (1)